Effectiveness of Dapagliflozin for Weight Loss

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

August 4, 2018

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
PreDiabetesObesity, MorbidDiabetes Mellitus, Type 2
Interventions
DRUG

Dapagliflozin/Metformin

Two tablets of Metformin 850 mg every 12 hours were provided in combination with Dapagliflozin 10 mg per day. Each participant received diet and exercise intervention according to their BMI and current physical condition.

DRUG

Metformin

Two tablets of Metformin 850 mg every 12 hours were provided. Each participant received diet and exercise intervention according to their BMI and current physical condition.

Trial Locations (1)

06720

Hospital de Especialidades Centro Médico Nacional Siglo XXI, Mexico City

All Listed Sponsors
lead

Centro Medico Nacional Siglo XXI IMSS

OTHER

NCT03968224 - Effectiveness of Dapagliflozin for Weight Loss | Biotech Hunter | Biotech Hunter